SynopsisThe global market for Large Volume Parenteral (LVP) was valued at US$ 11230 million in the year 2024 and is projected to reach a revised size of US$ 15480 million by 2031, growing at a CAGR of 4.8% during the forecast period. Large volume parenteral prep.....
SynopsisThe global market for Budesonide Inhalation Aerosol was valued at US$ 252 million in the year 2024 and is projected to reach a revised size of US$ 405 million by 2031, growing at a CAGR of 7.0% during the forecast period. Budesonide is used to help preve.....
SynopsisThe global market for Nitric Oxide was valued at US$ 1282 million in the year 2024 and is projected to reach a revised size of US$ 2223 million by 2031, growing at a CAGR of 8.3% during the forecast period. Nitric oxide is a chemical compound in gas form.....
SynopsisThe global market for O-arm 3D Imaging Navigator was valued at US$ 376 million in the year 2024 and is projected to reach a revised size of US$ 566 million by 2031, growing at a CAGR of 5.2% during the forecast period. The O-arm 3D Imaging Navigator is a.....
SynopsisThe global market for Cutaneous Fibrosis Treatment was valued at US$ 643 million in the year 2024 and is projected to reach a revised size of US$ 974 million by 2031, growing at a CAGR of 6.2% during the forecast period. Cutaneous fibrosis is the accumul.....
SynopsisThe global market for Tracheostomy Tube was valued at US$ 201 million in the year 2024 and is projected to reach a revised size of US$ 260 million by 2031, growing at a CAGR of 3.8% during the forecast period. A tracheostomy tube is a medical device inse.....
SynopsisThe global market for Dual-Antibody ADC was valued at US$ 522 million in the year 2024 and is projected to reach a revised size of US$ 736 million by 2031, growing at a CAGR of 5.7% during the forecast period. Dual-Antibody ADC is an innovative targeted .....
SynopsisThe global market for Rosacea Treatments was valued at US$ 13.8 million in the year 2024 and is projected to reach a revised size of US$ 17.2 million by 2031, growing at a CAGR of 3.2% during the forecast period. Rosacea is a common skin condition charac.....
SynopsisThe global market for Small Nucleic Acid Drugs for Hepatitis B was valued at US$ 857 million in the year 2024 and is projected to reach a revised size of US$ 1224 million by 2031, growing at a CAGR of 5.6% during the forecast period. Small Nucleic Acid D.....
Global Skin Analysis Instrument Market was estimated to be worth USD XX billion in 2024 and is projected to grow at a CAGR of XX% from 2025 to 2031 The study has considered the base year as 2024, which estimates the market segment of market and the forecast period is 2.....
